When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
NVCR - Buy NovoCure: The First Mover In The New Modality In Cancer Treatment
NovoCure Limited
NovoCure (NVCR) is an innovative medical device company that is developing the fourth modality in cancer treatment. I rate NovoCure a buy. As the lead and only developer of Tumor Treating Field (TTField), the company has the potential to gain a significant share of the vast cancer treatment market. Even though the valuation of NovoCure shares seems rich, I think the market does not fully appreciate the potential of this treatment modality. Hence, investing in NovoCure at current share price can produce multi-bagger returns in five to ten years. This article intends to